Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

NGM Biopharmaceuticals, Inc. - Common Stock (NQ:NGM)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 4, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	-
Bid (Size)	1.550 (545)
Ask (Size)	1.610 (1)
Prev. Close	1.540
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	78,049,340
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

NGM Bio Announces Closing of Tender Offer

April 05, 2024

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting

March 19, 2024

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

Performance

More News

NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc. - NGM

March 13, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Looking Into NGM Biopharmaceuticals's Recent Short Interest ↗

January 19, 2024

Via Benzinga

Why NGM Biopharmaceuticals Stock Is Blasting Higher ↗

January 02, 2024

Via Benzinga

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results

March 11, 2024

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

February 27, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 26, 2024

Via Benzinga

Why Is Cancer-Focused NGM Biopharmaceuticals Stock Trading Lower On Monday? ↗

February 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 26, 2024

Via Benzinga

NGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of NGM Biopharmaceuticals, Inc. Is Fair to Shareholders

February 26, 2024

From Halper Sadeh LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Agiliti, Inc. (NYSE – AGTI), NGM Biopharmaceuticals, Inc. (Nasdaq – NGM), VIZIO Holding Corp. (NYSE - VZIO), HireRight Holdings Corporation (NYSE – HRT)

February 26, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP

February 26, 2024

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

NGM Bio to Participate in the Cowen 44th Annual Health Care Conference

February 20, 2024

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

January 17, 2024

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

Why JetBlue Airways Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 09, 2024

Via Benzinga

NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need

January 09, 2024

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

January 02, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 02, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 01, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 29, 2023

Via Benzinga

B. Riley Securities Maintains Buy Rating for NGM Biopharmaceuticals: Here's What You Need To Know ↗

November 22, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 20, 2023

Via Benzinga

NGM Bio Presents Positive Phase 2b Results from the ALPINE 4 Trial of Aldafermin in Patients with Compensated Cirrhosis (F4) Due to NASH at AASLD The Liver Meeting®

November 13, 2023

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

NGM Bio to Participate in Upcoming Investor Conferences

November 07, 2023

From NGM Biopharmaceuticals, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is NGM Biopharmaceuticals, Inc. - Common Stock publicly traded?

Yes, NGM Biopharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does NGM Biopharmaceuticals, Inc. - Common Stock trade on?

NGM Biopharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for NGM Biopharmaceuticals, Inc. - Common Stock?

The ticker symbol for NGM Biopharmaceuticals, Inc. - Common Stock is NGM on the Nasdaq Stock Market

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.